‘Longevity gene’ may help prevent memory decline in elderly
January 13th, 2010 - 1:14 pm ICT by ANI ( Leave a comment )Washington, Jan 13 (ANI): Scientists at Albert Einstein College of Medicine of Yeshiva University have found a “longevity gene” that may help diminish age-related cognitive decline in elderly.
With the new finding, they have stepped up efforts to develop drugs that mimic the gene’s effect and help protect against Alzheimer’s disease.
“Most work on the genetics of Alzheimer’s disease has focused on factors that increase the danger,” said Dr Richard B. Lipton, the Lotti and Bernard Benson Faculty Scholar in Alzheimer’s Disease and professor and vice chair in the Saul R. Korey Department of Neurology at Einstein and senior author of the paper.
In a 2003 study, Lipton and his colleagues identified the cholesteryl ester transfer protein (CETP) gene variant as a “longevity gene” in a population of Ashkenazi Jews.
The favourable CETP gene variant increases blood levels of high-density lipoprotein (HDL) - the so-called good cholesterol - and also results in larger-than-average HDL and low-density lipoprotein (LDL) particles.
In the new study, researchers hypothised CETP longevity gene might also be associated with less cognitive decline, as people grow older.
They examined data from 523 participants from the Einstein Aging Study.
“We found that people with two copies of the longevity variant of CETP had slower memory decline and a lower risk for developing dementia and Alzheimer’s disease,” said Dr Amy E. Sanders, assistant professor in the Saul R. Korey Department of Neurology at Einstein and lead author of the paper.
“More specifically, those participants who carried two copies of the favorable CETP variant had a 70 percent reduction in their risk for developing Alzheimer’s disease compared with participants who carried no copies of this gene variant,” Sanders added.
The favourable gene variant alters CETP so that the protein functions less well than usual.
Lipton said drugs are now being developed that duplicate this effect on the CETP protein.
“These agents should be tested for their ability to promote successful aging and prevent Alzheimer’s disease,” he added.
The findings are published in Journal of the American Medical Association. (ANI)
- High levels of 'good' cholesterol linked to lower risk of Alzheimer's - Dec 14, 2010
- Increasing blood levels of 'good' cholesterol 'cuts heart disease risk' - Nov 18, 2010
- Lowering cholesterol transfer protein activity linked to heart disease risk - Dec 16, 2009
- Want to live beyond 100, take 'magic pill' - May 12, 2010
- Adults with large waistlines, high blood pressure 'at high risk for memory loss' - Feb 03, 2011
- 'Good' cholesterol drug may help diabetics - Jul 19, 2011
- Exercise important for those at special risk for Alzheimer's - Nov 19, 2010
- Gene harms brain decades before Alzheimer's outbreak - May 15, 2011
- Brain size linked to early Alzheimer's risk - Dec 28, 2011
- Super-early signs of Alzheimer's revealed - Dec 17, 2010
- Additional genes linked to age-related macular degeneration identified - Apr 13, 2010
- Now, 3 biomarkers in spinal fluid could classify patients with Alzheimer's - Aug 10, 2010
- Migraine 'doubles heart attack risk' - Feb 11, 2010
- Indications of Alzheimer's may be evident decades before first signs - Mar 29, 2011
- High levels of 'good' cholesterol may decrease bowel cancer risk - Mar 08, 2011
Tags: albert einstein, albert einstein college, albert einstein college of medicine, albert einstein college of medicine of yeshiva universi, ashkenazi jews, bernard benson, cholesteryl ester transfer protein, cognitive decline, college of medicine, einstein college of medicine, faculty scholar, gene variant, good cholesterol, high density lipoprotein, korey, ldl particles, low density lipoprotein, memory decline, protein functions, richard b lipton
